REQUEST A DEMO
Total
USD $0.00
Search more companies

Inpharm Sp. z o.o. (Warsaw) (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Pharmaceutical Preparation Manufacturing | Medical Equipment and Supplies Manufacturing | Chemical and Allied Products Merchant Wholesalers | Warehousing and Storage | Other Information Services | Accounting, Tax Preparation, Bookkeeping, and Payroll Services | Computer Systems Design and Related Services
Full name: Inpharm Sp. z o.o. Profile Updated: March 21, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Polish Download a sample report

Inpharm Sp. z o.o. (Warsaw) operates as a pharmaceutical-market service platform focused on parallel import, wholesale distribution and related value-added services for medical products; the company sources products via an established supplier network across the European Union and supplies the Polish market, with operations centered on distribution to pharmacies and other trade channels. Core activities include parallel import and commercialization of medicines originating in the EU for sale in Poland, supported by regulatory permits and an operating model designed to ensure product availability and competitive pricing. The product portfolio spans prescription medicines, OTC products, medical devices/medical products and cosmetics, including reimbursed products as well as closed-treatment products; the company also maintains an own-brand segment within its portfolio. Inpharm provides contract services including repacking and serialisation (including FMD-related product safety features and traceability), executed in controlled environmental conditions and governed by GMP-based procedures, with documented quality controls and qualified-person series release support. The company also provides controlled-temperature warehousing and logistics (including storage at 15-25C and 2-8C) and offers third-party storage and delivery solutions for other entrepreneurs under controlled conditions; additional commercial services include warehouse and office space rental in Warsaw and advisory services for market entry, including market analysis and distribution planning for new products. Distribution capabilities include both owned and contracted temperature-monitored vehicle capacity, supporting cold-chain and ambient transport, and nationwide reach through deliveries to a broad network of pharmacies, including chains and purchasing groups. Key assets include a dedicated repacking/serialisation hall, warehouse infrastructure in Warsaw, and integrated distribution operations designed to support compliance, speed and continuity of supply; strategic positioning centers on leadership in the Polish parallel import market, leveraging EU sourcing scale, operational efficiency, compliance-led quality management and comprehensive end-to-end services spanning sourcing, adaptation, warehousing and nationwide delivery.

Headquarters
Ul. Strumykowa 28/11
Warsaw; Mazowieckie; Postal Code: 03-138

Contact Details: Purchase the Inpharm Sp. z o.o. (Warsaw) report to view the information.

Website: http://www.inpharm.pl

Basic Information
Total Employees:
Purchase the Inpharm Sp. z o.o. (Warsaw) report to view the information.
Registered Capital:
Purchase the Inpharm Sp. z o.o. (Warsaw) report to view the information.
Financial Auditors:
Purchase the Inpharm Sp. z o.o. (Warsaw) report to view the information.
Incorporation Date:
April 20, 2006
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Inpharm Sp. z o.o. (Warsaw) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
11.26%
Total operating revenue
11.32%
Operating Profit/Loss (EBIT)
13.3%
EBITDA
14.17%
Net Profit/Loss for the Period
24.35%
Total Assets
13.47%
Total Equity
10.67%
Operating Profit Margin (ROS)
0.04%
Net Profit Margin
0.13%
Return on Equity (ROE)
1.06%
Debt/Equity
-3.22%
Quick Ratio
-0.03%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?